Enhanced surgical site infection surveillance following caesarean section: experience of a multicentre collaborative post-discharge system.

The caesarean section rate in the UK has more than doubled during the last two decades and is continuing to rise. The majority of studies carried out to determine the incidence of infection associated with this procedure have been restricted to the inpatient stay, which may give misleading results. Women undergoing caesarean section have routine contact with a community midwife after discharge. This provided an opportunity to assess whether a collaborative surveillance approach between hospital and community staff was feasible using routinely available information. Following a successful pilot study, 11 maternity units in the East Midlands participated in an extended study. Complete records were available for 5,563 (88%) women. Overall, 758 (13.6%) wound problems were reported, 84% of which developed after discharge. Of these, 488 (8.9%) met national definitions for surgical site infection (SSI); however, there was a marked inter-unit difference in incidence, ranging from 2.9% to 17.9%. Statistical models were used to examine these differences using 12 possible risk factors. Five risk factors were found to be significantly associated with the development of a surgical site infection: body mass index, age, blood loss, method of wound closure and emergency procedures. These results suggest that caesarean section is associated with high infectious morbidity, the extent of which would have been considerably underestimated without post-discharge monitoring. Almost all women with wound problems were treated with antibiotics, regardless of how minor the problem, with 97% being prescribed in the community. This indicates a requirement for local review of antibiotic prescribing practice.

A user evaluation of the Nosocomial Infection National Surveillance System: surgical site infection module.

The Nosocomial Infection National Surveillance Scheme (NINSS) enables hospitals in England to undertake surveillance of healthcare associated infection, compare their results with national aggregated data, and use the information to improve patient care. A surgical site infection (SSI) module was introduced in 1997, and participation has increased steadily since its inception. This survey was undertaken to assess the views of users on the current service, and how the module should be developed to best meet their needs and resources. Survey forms were sent to infection control teams (ICTs) at the 113 hospitals that had participated at any time during the first three years of the programme. The response rate was 90% (102). The views of users were generally very positive and indicated considerable support for the approach to this type of surveillance. The ability to compare hospital infection rates with national data, the availability of standardized surveillance methods, and centralized data analysis and report production were key reasons for participation for over 80% of users. Most did not wish to see any major changes made to the protocol, although more than a third of users suggested additional data items. Overall, users were satisfied with both the content and timescale for receipt of feedback reports, and 77% disseminated them to at least three groups of clinicians and managers. The majority of ICTs (89%) gave the results directly to the surgeons. For some users (29%) it was too early to assess the value of the surveillance. Of the remainder, although results provided evidence of good performance for some, 46% identified high rates of SSI in one or more groups of surgical patients. In about two-thirds of these hospitals, a review or change in clinical practice was initiated as a result. Three main areas for development were identified: an extended range of surgical procedures, post-discharge surveillance and improved local data collection and analysis systems. Users said they would also like training in handling and interpreting surveillance data. These needs should be addressed in order to ensure the continuing success of national surveillance.

The changing pattern of venous thromboembolic disease.

A review of 14,667 necropsy reports for every year from 1965 to 1990 and 6,436 diagnostic venograms performed from 1976 to 1990 was undertaken at a single teaching hospital. A progressive reduction in the percentage of necropsies reporting fatal pulmonary embolism from 6.1 to 2.1%, occurred over the 25-year period (chi(2) tests for linear trend with time p < 0.00001). Over the last decade, there has been a significant reduction in the rate of venographically diagnosed postoperative deep vein thrombosis (DVT) from 49.9 to 24.7 per 100,000 population (p < 0.0001) which was in marked contrast to the constant rate of non-postoperative DVT. Our findings suggest that the introduction of thromboprophylactic measures, in addition to changes in hospital practice, may have had a highly significant effect on the pattern of this serious, but potentially avoidable disease.

Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group.

Low-molecular-weight heparin (LMWH) is effective in the prevention of postoperative venous thromboembolism but does it have the safety advantages over standard heparin (SH) that have been claimed? In a multicentre randomised trial in 3809 patients undergoing major abdominal surgery (1894 LMWH, 1915 SH) heparin was given preoperatively and continued for at least 5 postoperative days. Patients were assessed in the postoperative period and were followed up for at least 4 weeks, the emphasis being on safety. Major bleeding events occurred in 69 (3.6%) patients in the LMWH group and 91 (4.8%) patients in the SH group (relative risk 0.77, 95% confidence interval 0.56-1.04; p = 0.10). 93 indices of major bleeding were observed in the 69 LMWH patients and 141 in the SH patients. (p = 0.058). Severe bleeding was less frequent in the LMWH group (1.0% vs 1.9%; p = 0.02), as was wound haematoma (1.4% vs 2.7%; p = 0.007). Bleeding episodes with LMWH were less likely to lead to further surgery to evacuate a haematoma or to control bleeding, and injection site bruising was also less common in the LMWH group. No significant differences were found in the efficacy of the two agents. Perioperative death rates were 3.3% in the LMWH group and 2.5% in the SH group; pulmonary emboli were detected in 0.7% and 0.7%; and deep-vein thrombosis was diagnosed in 0.6% of patients in each group. Follow-up was done on 91% of 3699 evaluable patients. There were 19 further deaths (10 LMWH, 9 SH group) and 25 patients with thromboembolic complications (15 and 10). Of the 3 patients with fatal pulmonary emboli during follow-up 2 had received LMWH and 1 SH. The two drugs were of similar efficacy. The primary end point, the frequency of major bleeding, showed a 23% reduction in the LMWH group, but this difference was not significant. The secondary safety end points revealed that LMWH was significantly better than SH. Fatal pulmonary embolism occurs rarely (0.09%) following discharge from hospital so the cost benefit ratio would not justify prolonged prophylaxis in this setting.

Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis.

A prospective, double-blind, randomized, controlled clinical trial compared the efficacy and safety of fixed combinations of low-molecular weight heparin or standard unfractionated heparin plus dihydroergotamine mesylate in the prevention of deep vein thrombosis in high-risk patients undergoing elective major abdominal surgery. Two hundred patients, with a mean age of 66.6 years and almost half with malignancy, were allocated to receive either 5,000 IU unfractionated heparin plus 0.5 mg dihydroergotamine mesylate twice daily or 1,500 IU low-molecular weight heparin plus 0.5 mg dihydroergotamine mesylate once daily together with one placebo injection per day. Treatment was commenced 2 hours preoperatively and continued for at least 7 days. The incidence of deep vein thrombosis, determined by radiolabelled fibrinogen uptake and phlebography, was 11 percent in the unfractionated heparin plus dihydroergotamine mesylate group and 11.4 percent in the low-molecular weight heparin and dihydroergotamine mesylate group. Neither these figures nor those for major proximal thrombi proved significantly different. Of the four parameters used to assess hemorrhagic complications, only the decrease in postoperative hemoglobin levels in the low-molecular weight and dihydroergotamine mesylate group reached statistical significance. These results indicate that once-daily prophylaxis with a combination of low-molecular weight heparin and dihydroergotamine is safe, effective, and convenient in high-risk patients undergoing major abdominal surgery.

Life skills groups for adolescent foster children.

A curriculum designed by child development specialists in collaboration with child care workers and other experts gives workers concrete tools for conducting life skills groups with adolescents.

Prophylaxis for postoperative deep-vein thrombosis. Synergistic effect of heparin and dihydroergotamine.

Randomized clinical trials in 300 patients undergoing major abdominal surgery or hip replacement arthroplasty were performed to investigate the efficacy of dihydroergotamine mesylate, heparin calcium, or a combination of dihydroergotamine with heparin in preventing postoperative deep-vein thrombosis (DVT). The diagnosis of DVT was established by an uptake test using fibrinogen labeled with iodine 125; in patients undergoing hip replacement, phlebography was also employed to confirm or refute the presence of isotopic thrombi. The data indicate that the combination of dihydroergotamine and heparin is more effective than heparin or dihydroergotamine alone in preventing DVT.